The US Food and Drug Administration (FDA) has granted accelerated approval for Ireland-headquartered Jazz Pharmaceuticals’ ...

Merck & Co (NYSE: MRK) was the biggest spender in pharma M&A during July. The US pharma giant boldly splashed out around $10 ...

Swiss generics and biosimilar major Sandoz today presented its financial results for the first half of 2025. and reiterated ...

Hungary’s largest drugmaker Gedeon Richter has announced its financial results for the second quarter and first half year of 2025.

Denmark’s Novo Nordisk saw its shares fall 4.8% to 291.20 kroner by early afternoon, after it posted financials results for ...

Germany’s Bayer experienced a nightmare day’s trading Wednesday, with shares in the life sciences company more than 8% lower ...

Pharmaceutical regulation is undergoing its biggest shake-up in decades. On both sides of the Atlantic, policymakers are ...

The US Food and Drug Administration (FDA) has approved an expanded indication of the intravenous (IV) formulation of South ...

Biologics-focused contract manufacturing and research organization Abenza announced that Geoffrey Glass has been appointed ...

Danish diabetes and obesity giant Novo Nordisk has announced the filing of 14 new lawsuits to safeguard patients from unsafe ...

Teva Pharmaceutical has received a green light from the US regulator for its biologic Ajovy (fremanezumab) to be used for ...

Further evidence that US Department of Health and Human Services (HHS) secretary Robert F Kennedy Junior (RFK Jr) is willing ...